Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B

Title
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Authors
Keywords
Hepatitis B virus, Hepatitis B surface antigen, Hepatitis B e antigen, GS-4774, Nucleoside/nucleotide analogue, Phase II
Journal
JOURNAL OF HEPATOLOGY
Volume 65, Issue 3, Pages 509-516
Publisher
Elsevier BV
Online
2016-05-21
DOI
10.1016/j.jhep.2016.05.016

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started